179 related articles for article (PubMed ID: 32678144)
1. Bliss' and Loewe's additive and synergistic effects in Plasmodium falciparum growth inhibition by AMA1-RON2L, RH5, RIPR and CyRPA antibody combinations.
Azasi Y; Gallagher SK; Diouf A; Dabbs RA; Jin J; Mian SY; Narum DL; Long CA; Gaur D; Draper SJ; Fay MP; Miller LH; Miura K
Sci Rep; 2020 Jul; 10(1):11802. PubMed ID: 32678144
[TBL] [Abstract][Full Text] [Related]
2. Plasmodium falciparum Cysteine-Rich Protective Antigen (CyRPA) Elicits Detectable Levels of Invasion-Inhibitory Antibodies during Natural Infection in Humans.
Mian SY; Somanathan A; Chaddha K; Pandey AK; Singh H; Krishna S; Chaturvedi N; Uchoi S; Shukla MM; Bharti PK; Singh N; Chauhan VS; Gaur D
Infect Immun; 2022 Jan; 90(1):e0037721. PubMed ID: 34694918
[TBL] [Abstract][Full Text] [Related]
3. RH5.1-CyRPA-Ripr antigen combination vaccine shows little improvement over RH5.1 in a preclinical setting.
Healer J; Thompson JK; Mackwell KL; Browne CD; Seager BA; Ngo A; Lowes KN; Silk SE; Pulido D; King LDW; Christen JM; Noe AR; Kotraiah V; Masendycz PJ; Rajagopalan R; Lucas L; Stanford MM; Soisson L; Diggs C; Miller R; Youll S; Wycherley K; Draper SJ; Cowman AF
Front Cell Infect Microbiol; 2022; 12():1049065. PubMed ID: 36605129
[TBL] [Abstract][Full Text] [Related]
4. Development of an improved blood-stage malaria vaccine targeting the essential RH5-CyRPA-RIPR invasion complex.
Williams BG; King LDW; Pulido D; Quinkert D; Lias AM; Silk SE; Ragotte RJ; Davies H; Barrett JR; McHugh K; Rigby CA; Alanine DGW; Barfod L; Shea MW; Cowley LA; Dabbs RA; Pattinson DJ; Douglas AD; Lyth OR; Illingworth JJ; Jin J; Carnrot C; Kotraiah V; Christen JM; Noe AR; MacGill RS; King CR; Birkett AJ; Soisson LA; Skinner K; Miura K; Long CA; Higgins MK; Draper SJ
Nat Commun; 2024 Jun; 15(1):4857. PubMed ID: 38849365
[TBL] [Abstract][Full Text] [Related]
5. Identification and Immune Assessment of T Cell Epitopes in Five
Kotraiah V; Phares TW; Terry FE; Hindocha P; Silk SE; Nielsen CM; Moise L; Tucker KD; Ashfield R; Martin WD; De Groot AS; Draper SJ; Gutierrez GM; Noe AR
Front Immunol; 2021; 12():690348. PubMed ID: 34305923
[TBL] [Abstract][Full Text] [Related]
6. Functional Comparison of Blood-Stage
Illingworth JJ; Alanine DG; Brown R; Marshall JM; Bartlett HE; Silk SE; Labbé GM; Quinkert D; Cho JS; Wendler JP; Pattinson DJ; Barfod L; Douglas AD; Shea MW; Wright KE; de Cassan SC; Higgins MK; Draper SJ
Front Immunol; 2019; 10():1254. PubMed ID: 31214195
[TBL] [Abstract][Full Text] [Related]
7. Structure of Plasmodium falciparum Rh5-CyRPA-Ripr invasion complex.
Wong W; Huang R; Menant S; Hong C; Sandow JJ; Birkinshaw RW; Healer J; Hodder AN; Kanjee U; Tonkin CJ; Heckmann D; Soroka V; Søgaard TMM; Jørgensen T; Duraisingh MT; Czabotar PE; de Jongh WA; Tham WH; Webb AI; Yu Z; Cowman AF
Nature; 2019 Jan; 565(7737):118-121. PubMed ID: 30542156
[TBL] [Abstract][Full Text] [Related]
8. The RH5-CyRPA-Ripr Complex as a Malaria Vaccine Target.
Ragotte RJ; Higgins MK; Draper SJ
Trends Parasitol; 2020 Jun; 36(6):545-559. PubMed ID: 32359873
[TBL] [Abstract][Full Text] [Related]
9. Antibodies from malaria-exposed Malians generally interact additively or synergistically with human vaccine-induced RH5 antibodies.
Willcox AC; Huber AS; Diouf A; Barrett JR; Silk SE; Pulido D; King LDW; Alanine DGW; Minassian AM; Diakite M; Draper SJ; Long CA; Miura K
Cell Rep Med; 2021 Jul; 2(7):100326. PubMed ID: 34337556
[TBL] [Abstract][Full Text] [Related]
10. Immunoglobulin G subclass and antibody avidity responses in Malian children immunized with Plasmodium falciparum apical membrane antigen 1 vaccine candidate FMP2.1/AS02
Berry AA; Gottlieb ER; Kouriba B; Diarra I; Thera MA; Dutta S; Coulibaly D; Ouattara A; Niangaly A; Kone AK; Traore K; Tolo Y; Mishcherkin V; Soisson L; Diggs CL; Blackwelder WC; Laurens MB; Sztein MB; Doumbo OK; Plowe CV; Lyke KE
Malar J; 2019 Jan; 18(1):13. PubMed ID: 30658710
[TBL] [Abstract][Full Text] [Related]
11. Anti-apical-membrane-antigen-1 antibody is more effective than anti-42-kilodalton-merozoite-surface-protein-1 antibody in inhibiting plasmodium falciparum growth, as determined by the in vitro growth inhibition assay.
Miura K; Zhou H; Diouf A; Moretz SE; Fay MP; Miller LH; Martin LB; Pierce MA; Ellis RD; Mullen GE; Long CA
Clin Vaccine Immunol; 2009 Jul; 16(7):963-8. PubMed ID: 19439523
[TBL] [Abstract][Full Text] [Related]
12. Overcoming allelic specificity by immunization with five allelic forms of Plasmodium falciparum apical membrane antigen 1.
Miura K; Herrera R; Diouf A; Zhou H; Mu J; Hu Z; MacDonald NJ; Reiter K; Nguyen V; Shimp RL; Singh K; Narum DL; Long CA; Miller LH
Infect Immun; 2013 May; 81(5):1491-501. PubMed ID: 23429537
[TBL] [Abstract][Full Text] [Related]
13. Defining the antigenic diversity of Plasmodium falciparum apical membrane antigen 1 and the requirements for a multi-allele vaccine against malaria.
Drew DR; Hodder AN; Wilson DW; Foley M; Mueller I; Siba PM; Dent AE; Cowman AF; Beeson JG
PLoS One; 2012; 7(12):e51023. PubMed ID: 23227229
[TBL] [Abstract][Full Text] [Related]
14. Immunization with a functional protein complex required for erythrocyte invasion protects against lethal malaria.
Srinivasan P; Ekanem E; Diouf A; Tonkin ML; Miura K; Boulanger MJ; Long CA; Narum DL; Miller LH
Proc Natl Acad Sci U S A; 2014 Jul; 111(28):10311-6. PubMed ID: 24958881
[TBL] [Abstract][Full Text] [Related]
15. Passive immunoprotection of Plasmodium falciparum-infected mice designates the CyRPA as candidate malaria vaccine antigen.
Dreyer AM; Matile H; Papastogiannidis P; Kamber J; Favuzza P; Voss TS; Wittlin S; Pluschke G
J Immunol; 2012 Jun; 188(12):6225-37. PubMed ID: 22593616
[TBL] [Abstract][Full Text] [Related]
16. The Structure of the Cysteine-Rich Domain of Plasmodium falciparum P113 Identifies the Location of the RH5 Binding Site.
Campeotto I; Galaway F; Mehmood S; Barfod LK; Quinkert D; Kotraiah V; Phares TW; Wright KE; Snijders AP; Draper SJ; Higgins MK; Wright GJ
mBio; 2020 Sep; 11(5):. PubMed ID: 32900802
[No Abstract] [Full Text] [Related]
17. Characterization of AMA1-RON2L complex with native gel electrophoresis and capillary isoelectric focusing.
Zhu D; Dai W; Srinivasan P; McClellan H; Braden D; Allee-Munoz A; Hurtado PAG; Miller LH; Duffy PE
Electrophoresis; 2022 Feb; 43(3):509-515. PubMed ID: 34679212
[TBL] [Abstract][Full Text] [Related]
18. Antibody Combinations Targeting the Essential Antigens CyRPA, RH5, and MSP-119 Potently Neutralize Plasmodium falciparum Clinical Isolates From India and Africa.
Singh H; Mian SY; Pandey AK; Krishna S; Anand G; Reddy KS; Chaturvedi N; Bahl V; Hans N; Shukla MM; Bassat Q; Mayor A; Miura K; Bharti PK; Long C; Singh N; Chauhan VS; Gaur D
J Infect Dis; 2021 Jun; 223(11):1953-1964. PubMed ID: 32989463
[TBL] [Abstract][Full Text] [Related]
19. Strain-Dependent Inhibition of Erythrocyte Invasion by Monoclonal Antibodies Against
Knudsen AS; Björnsson KH; Bassi MR; Walker MR; Kok A; Cristinoi B; Jensen AR; Barfod L
Front Immunol; 2021; 12():716305. PubMed ID: 34447381
[TBL] [Abstract][Full Text] [Related]
20. P113 is a merozoite surface protein that binds the N terminus of Plasmodium falciparum RH5.
Galaway F; Drought LG; Fala M; Cross N; Kemp AC; Rayner JC; Wright GJ
Nat Commun; 2017 Feb; 8():14333. PubMed ID: 28186186
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
